UNICEF in new African vaccine drive

UNICEF (UN Children's Fund), has launched a massive vaccination campaign across the Horn of Africa to protect 2.5 million children against diseases like measles, which can be deadly for malnourished children. This drive would include a strategy to vaccinate every child in Somalia (under the age of 15) against measles.

Measles cases were confirmed in Southern and Central Somalia and cases of acute watery diarrhea in Mogadishu, Afgoye, Baidoa and Lower Shabelle regions were detected. With so many women and children on the move, the challenge is to reach all children to prevent new outbreaks of disease say officials.

UNICEF began its vaccination campaign last week in Southern Somalia where vaccination coverage is just 26 per cent - one of the lowest in the world. Over 85,000 women and young children were vaccinated in eight districts of Mogadishu including in overcrowded internally displaced camps. In Gedo region, preparations are on-going for a measles, Vitamin A and de-worming and tetanus toxoid campaign planned in 6 districts to reach over 125,000 women and young children.

UNICEF is also working in conjunction with the Kenya Ministry of Health and WHO, to vaccinate children living in the host communities around Dadaab refugee camp in Northern Kenya. The campaign will target almost 203,000 children under five with measles and polio vaccines, together with Vitamin A and de-worming tablets. The campaign in northern Kenya will continue until Friday and target children in Garissa, Fafi, Lagdera and Wajir South.

This is a child survival crisis,” said Elhadj As Sy, UNICEF Regional Director for Eastern and Southern Africa. “Children don't die just because they don't have enough food. In various stages of malnutrition, they are more prone to sickness and disease. As big a challenge as the rates of malnutrition pose, the danger for children extends even further.”

Dennis McKinlay, Executive Director at UNICEF NZ, said, “UNICEF is massively scaling up our operations to reach children in drought affected areas with emergency and preventative assistance. The focus is on providing integrated interventions that address various aspects of a child's survival and development including providing health services and vaccinations. We have a huge challenge in the coming weeks and months but we have the expertise, experience and partnerships to reach every child who needs our help - all we need is funding. Contributions from generous Kiwis are already saving lives but with more donations we can do so much more.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). UNICEF in new African vaccine drive. News-Medical. Retrieved on January 31, 2023 from https://www.news-medical.net/news/20110727/UNICEF-in-new-African-vaccine-drive.aspx.

  • MLA

    Mandal, Ananya. "UNICEF in new African vaccine drive". News-Medical. 31 January 2023. <https://www.news-medical.net/news/20110727/UNICEF-in-new-African-vaccine-drive.aspx>.

  • Chicago

    Mandal, Ananya. "UNICEF in new African vaccine drive". News-Medical. https://www.news-medical.net/news/20110727/UNICEF-in-new-African-vaccine-drive.aspx. (accessed January 31, 2023).

  • Harvard

    Mandal, Ananya. 2018. UNICEF in new African vaccine drive. News-Medical, viewed 31 January 2023, https://www.news-medical.net/news/20110727/UNICEF-in-new-African-vaccine-drive.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Experimental vaccine against Marburg virus shows promise in first-in-human clinical trial